Whitehawk Therapeutics to Showcase Innovations at 2026 Stifel Virtual Targeted Oncology Forum#United_States#Morristown#Whitehawk_Therapeutics#ADC_Technologies#oncology_therapeutics
Whitehawk Therapeutics to Showcase Innovations at 2026 Stifel Virtual Targeted Oncology Forum
Whitehawk Therapeutics will present its advanced antibody drug conjugate technologies during the 2026 Stifel Virtual Targeted Oncology Forum, highlighting innovations in cancer treatment.
third-news.com
May 15, 2026 at 12:05 PM
Whitehawk Therapeutics to Showcase Innovations at 2026 Stifel Virtual Targeted Oncology Forum#United_States#Morristown#Whitehawk_Therapeutics#ADC_Technologies#oncology_therapeutics
Piramal Pharma Solutions and IntoCell Unite to Enhance Bioconjugate Technologies#India#Mumbai#Piramal_Pharma#ADC_Technologies#IntoCell
Piramal Pharma Solutions and IntoCell Unite to Enhance Bioconjugate Technologies
Piramal Pharma Solutions partners with IntoCell to expand bioconjugate capabilities, leveraging advanced drug-linker technologies to boost innovation.
third-news.com
October 30, 2025 at 5:34 AM
Piramal Pharma Solutions and IntoCell Unite to Enhance Bioconjugate Technologies#India#Mumbai#Piramal_Pharma#ADC_Technologies#IntoCell
SparX Biopharmaceutical Enters Collaboration with Mitsubishi Tanabe Pharma to Innovate Antibody-Drug Conjugate Technologies#USA#Chicago#Mitsubishi_Tanabe#SparX_Biopharmaceutical#ADC_Technologies
SparX Biopharmaceutical Enters Collaboration with Mitsubishi Tanabe Pharma to Innovate Antibody-Drug Conjugate Technologies
SparX Biopharmaceutical Corp has formed a strategic research partnership with Mitsubishi Tanabe Pharma to develop groundbreaking antibody-drug conjugate therapeutics.
third-news.com
May 15, 2025 at 6:06 PM
SparX Biopharmaceutical Enters Collaboration with Mitsubishi Tanabe Pharma to Innovate Antibody-Drug Conjugate Technologies#USA#Chicago#Mitsubishi_Tanabe#SparX_Biopharmaceutical#ADC_Technologies